Problem drug raid rumors worry Nan Xiao Hong Chi Pharmaceutical - Hong Chi Pharmaceutical - pharmace

Not wake up from the happiness of the Hainan Kang Chi Pharmaceutical Co., Ltd. (hereinafter referred to as Hong Chi Pharmaceutical), was suddenly attacked rumors.



4 2, Hong Chi Pharmaceutical GEM IPO than by will, to become the first Hainan GEM listed companies only.



The same day, from the media in two articles refer to the "side effects of nimesulide leading products more" and "put out of medicine in rural areas as new medicines harm a child", caused uproar in the industry.



Hong Chi Pharmaceutical really get out of medicine when the new medicines, or suffered unredressed injustice? Hong Chi Pharmaceutical fully clarified



Ruizhi Qing Zhi Kang is the leading pharmaceutical products, chemical name nimesulide particles. Nimesulide is a non-steroidal anti-inflammatory drug, has significant anti-inflammatory, analgesic and antipyretic effects, mainly for the treatment of osteoarthritis, acute inflammation, pain, primary dysmenorrhea, and fever. It was originally developed by the Swiss Helsinn, 1985 by Roche Italy for the first time in public, is currently used in 50 countries. Hong Chi Pharmaceutical in 2002, officially the drug on the market.



Allegedly Rui Zhiqing instructions listed on the "many side effects were staggering," especially in recent years, the severe liver toxicity has been reported more than foreign. "In the chemically highly controversial", 2002 Finland, Spain and even disabled the drug. Consultation with the mother's identity



Beijing, Shanghai and Guangzhou Children's Hospital doctors, the hospitals that have been using this drug, there has been no adverse reaction.



Guangzhou Children's Hospital, doctors told reporters: "is the medicine has side effects, hospitals were in strict accordance with the green prescription (pediatric medicinal green) to opening, has not received notice of the State can not use."



Reporter on this visit to Hainan Province Food and Drug Administration. But as of press time, still not received a reply. National Adverse Drug Reaction Monitoring Center published "Adverse Drug Reaction Information Bulletin" (November 2001? March 2010), no adverse effects of nimesulide on the communication of information.



Hong Chi Pharmaceutical vice president and general manager of Hong Jiangtao marketing company told Die Zeit interview, said, "people who understand medicine glance, the report is purely fabricated."



On the side, Hongjiang Tao said: "Rui Zhiqing has yet to find serious adverse events, not to harm the rural children."



Out for foreign reports, Hongjiang Tao said: "This is out of context, in fact, half reported that Finland, Spain, in 2004, has been restored to use," and that "the European Medicines Evaluation Agency (EMEA) at 2003 and 2007, two pairs of nimesulide were re-evaluation, evaluation results confirmed Nimesulide has a good benefit / loss characteristics, is safe and effective medicines. " Die Zeit foreign journalists access to relevant reports immediately and found to be true.



As to why there are so many side effects, instructions, Hongjiang Tao pointed out that the "statement is in accordance with SFDA requirements after careful research to modify and not arbitrarily compiled, and we set out details of side effects, is responsible for the patient's right to know. "



4 6, Hong Chi Medicine published the official web site home page "on the product Ruizhi Qing (nimesulide particles) of the statement," from 8 aspects of the report were fully clarified. Growth of venture capital, Shenzhen, South China Sea



executive director of Fu-lin's army also Die Zeit, said: "Rui Zhiqing very low incidence of adverse events, serious liver toxicity at present none of the cases."



Up to 98% of generic drugs in China





The e-commerce company in China offers quality products such as China CNC Machining Parts , Sheet Metal Parts, and more. For more , please visit machining parts supplier today!